| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 5, 2024Virtual Press Office and PR Newswire: General Trade show news
Pre-clinical data demonstrate robust anti-tumor activity and a novel off-the-shelf approach for GPC3+ solid tumors PHILADELPHIA, Nov. 5, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq:...
-
Nov 5, 2024Virtual Press Office and PR Newswire: General Trade show news
Collaboration focused on helping repairers easily identify OEM-recommended calibrations for collision-damaged vehicles equipped with Advanced Driver-Assistance Systems (ADAS) SAN DIEGO and...
-
Nov 5, 2024Virtual Press Office and PR Newswire: General Trade show news
Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of circular RNA medicines and unprecedented lipid nanoparticle (LNP) delivery solutions for oncology...
-
Nov 5, 2024Virtual Press Office and PR Newswire: General Trade show news
Data presented for the first time this week at Vascular Interventional Advances (VIVA) 2024 Conference Findings reinforce the clinical, health economic and cost benefits of computer assisted...
-
Nov 5, 2024Virtual Press Office and PR Newswire: General Trade show news
Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological...
